HK Stock Market Move | MAO GEPING (01318) rose more than 6%, with the stock price reaching a new high since listing. The company is currently in a rapid growth phase of brand momentum.
Maogeping (01318) rose more than 6%, hitting a high of 64.25 Hong Kong dollars during the trading session, reaching a new high since its listing. As of the time of writing, it has increased by 6.44%, trading at 62.8 Hong Kong dollars, with a turnover of 1.01 billion Hong Kong dollars.
MAO GEPING (01318) rose more than 6%, reaching a high of 64.25 Hong Kong dollars in intraday trading, hitting a new high since its listing. As of the time of reporting, it is up 6.44% to 62.8 Hong Kong dollars, with a trading volume of 101 million Hong Kong dollars.
On the news front, Huatai pointed out that the group's core brand MAO GEPING, as the first high-end beauty brand in China, has an IP value that is difficult to replicate. Its makeup category is based on high barriers and high stickiness of foundation, with skincare business synergistically enhancing efficiency, breaking through to higher price segments, and opening up growth ceilings; its offline counter channels consolidate brand image, cultivate high stickiness consumers; online channels achieve rapid growth by reaching new customer groups. The company is in a phase of rapid growth of brand momentum, and the bank is optimistic about the company's scarce brand value, category structure, channel endowment, and future growth potential, giving it a "buy" rating.
Minsheng Securities previously stated that the company is a leader in domestic high-end beauty brands, with scarce founder professional makeup artist IP assets, strong offline presence + steady online expansion. Against the backdrop of steady growth in the skincare industry and accelerated development in the makeup industry, it sees potential for the company's growth. CMSC believes that as a rare domestic high-end positioning makeup artist brand, MAO GEPING is currently in a phase of brand momentum growth, driven by popular product launches and a second-tier product matrix layout. They expect a steady increase in the number of stores, and with the expansion of the product matrix and increased repeat purchases, there is still room to increase same-store revenue.
Related Articles
CF PHARMTECH (02652) expects to achieve a adjusted net profit of approximately 30-35 million yuan in 2025, with stable business operations and continuous progress in innovative research and development.

US Stock Market Move | HSBC Holdings (HSBC.US) fell more than 2% amid reports of plans to cut 20,000 jobs over the next few years.

Service business cooling can't hide strong hardware performance! Morgan Stanley: Apple Inc. (AAPL.US) iPhone production increases significantly, shipments may exceed market expectations.
CF PHARMTECH (02652) expects to achieve a adjusted net profit of approximately 30-35 million yuan in 2025, with stable business operations and continuous progress in innovative research and development.
US Stock Market Move | HSBC Holdings (HSBC.US) fell more than 2% amid reports of plans to cut 20,000 jobs over the next few years.

Service business cooling can't hide strong hardware performance! Morgan Stanley: Apple Inc. (AAPL.US) iPhone production increases significantly, shipments may exceed market expectations.

RECOMMEND

State Reform Fund And Three Major Banks Backstop Voyah As It Secures Hong Kong’s First Auto IPO This Year
20/03/2026

Hong Kong IPO Irregularities Surface As Corner Placements And Retail Losses Emerge, Haizhi Technology Implicated
20/03/2026

Gold And Silver Experience Sharp Sell‑Off As Global Rate‑Hike Expectations Intensify
20/03/2026


